You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 120 No. 8, August 1985 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Stratified Outcome Comparison of Clindamycin-Gentamicin vs Chloramphenicol-Gentamicin for Treatment of Intra-abdominal Sepsis

E. Stan Lennard, MD, ScD; Barbara H. Minshew, PhD; E. Patchen Dellinger, MD; Margaret J. Wertz, MN, RN; David M. Heimbach, MD; George W. Counts, MD; Fritz D. Schoenknecht, MD; Marie B. Coyle, PhD

Arch Surg. 1985;120(8):889-898.


Abstract

• A randomized, prospective trial was conducted of 93 patients with operatively confirmed intra-abdominal sepsis. The study compared clindamycin-gentamicin and chloramphenicol-gentamicin for treatment of carefully stratified patient groups. Malnutrition, age over 65 years, shock, alcoholism, gastrointestinal tract bleeding, steroid administration, diabetes, obesity, and organ malfunction were present with equal frequencies in each group. The duration of antibiotic treatment averaged 81/2 days, and the average length of postoperative hospitalization was 29 days. Study antibiotics were changed for bacteriologic reasons in 11 patients taking clindamycin-gentamicin and 12 patients taking chloramphenicol-gentamicin (25% of the total), and two patients in the clindamycin-gentamicin group had a minor adverse reaction. Initial satisfactory clinical responses were obtained in 59 (63%) patients. Twenty-five patients (27%) subsequently developed unsatisfactory courses, but 48 (52%) patients remained well through the 30-day period. Septic-related mortality occurred in 18 (19%) patients, and two (2%) patients had unrelated deaths. There were no significant differences between the study regimens by the outcome criteria evaluated.

(Arch Surg 1985;120:889-898)



Author Affiliations

From the Departments of Surgery (Drs Lennard, Dellinger, and Heimbach and Ms Wertz), Medicine (Dr Counts), Laboratory Medicine (Drs Minshew, Schoenknecht, and Coyle), and Microbiology and Immunology (Dr Schoenknecht), University of Washington School of Medicine, Seattle.


Footnotes

Accepted for publication Jan 15, 1985.

Presented in part at the 21st Interscience Conference on Antimicrobial Agents and Chemotherapy, Las Vegas, Nov 4, 1981.

Reprint requests to Department of Surgery, University Hospital RF-25, Seattle, WA 98195 (Dr Lennard).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Reoperative Surgery for Periampullary Adenocarcinoma
McGuire et al.
Arch Surg 1991;126:1205-1212.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1985 American Medical Association. All Rights Reserved.